Our Database

Jerusalem Development Authority

Welcome to BIOJERUSALEM

BIOJERUSALEM is a one-stop connection for those who have made the science of life their business. It is at the vital heart of Jerusalem's thriving life sciences industry and serves as the primary resource for anyone involved in this exciting field.

BIOJERUSALEM is your portal to life sciences in a city like no other. Use our services to explore innovative opportunities to expand and grow your business ventures. We invite you to join the numerous biotechnology, pharmaceutical and medical device companies already realizing the enormous potential of Jerusalem.

Learn more how BIOJERUSALEM's resources can help you.


Click to view BIOJERUSALEM's Video Presentation

Latest News

May. 18, 2012
Avraham Pharmaceuticals Announces Commencement of a Phase 2 Study of Ladostigil for the Treatment of MCI

May. 17, 2012
The Israeli pharmacologist who kick- started marijuana research

May. 16, 2012
How the blind can ‘read,’ according to standard testing, shown in Hebrew University research

May. 16, 2012
Stem cell co Gamida Cell raises $10m

May. 16, 2012
FDA approves Medinol's PioNIR Plus stent

May. 15, 2012
BioLineRx Reports First Quarter 2012 Results

May. 1, 2012
Myrtle Potter & Company is retained by IMMUNE Pharmaceuticals as Business Development Advisor for NanomAb Drug Conjugates Portfolio

Apr. 27, 2012
BioLineRx Announces Extension of Patent for BCM (BL-1040) by USPTO

Events

Feb. 26-29, 2012
The 11th International Dead Sea Symposium (IDSS 2012) on Cardiac Arrhythmias and Device Therapy

May. 13-15, 2012
The International Conference on Integrative Medicine

May. 16-25, 2012
"Launching of the Burill Israel Fund"

May. 21-23, 2012
ILSI-Biomed Israel 2012

Jun. 20, 2012
כנס ירושלים ה-2 לרפואת משפחה וקהילה

Job Board

Click here to view new available positions in Jerusalem's life sciences industry.